NASDAQ:VCNX
Vaccinex, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.vaccinex.comipo date
Aug 09, 2018
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab, a humanized monoclonal antibody ...Show More
Earnings
Earnings Release in 16 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus